Christoph Irlbeck

Publications

Citations

H-Index

2020

Active since

Affiliations

Fraunhofer Institute for Toxicology and Experimental Medicine(Current)

University of Regensburg

University Hospital Regensburg

Christoph Irlbeck is an author at Fraunhofer Institute for Toxicology and Experimental Medicine specializing in cancer genetics, molecular diagnostics, and tumor biology.

ORCID

Top concepts

MedicineOncologyEngineeringCell BiologyBreast CancerTumor BiologyCancer BiologyCancer GeneticsSystems BiologyRadiation Oncology

Publications per year

2020–2021

Publications

Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency

Melanie Werner‐Klein, Ana Grujovic, Christoph Irlbeck et al. · Nature Communications · 2020 · 56 citations · Full text

<i>mdm2</i> gene amplification is associated with luminal breast cancer progression in humanized <scp>PDX</scp> mice and a worse outcome of estrogen receptor positive disease

Anja K. Wege, Eva‐Maria Rom‐Jurek, Paul Jank et al. · International Journal of Cancer · 2021 · 11 citations · Full text

Worse Outcome, Engineering, Breast Oncology +20

Rows per page

1–2 of 2